These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 12858176)

  • 1. Mutations in the genes encoding 11beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency.
    Draper N; Walker EA; Bujalska IJ; Tomlinson JW; Chalder SM; Arlt W; Lavery GG; Bedendo O; Ray DW; Laing I; Malunowicz E; White PC; Hewison M; Mason PJ; Connell JM; Shackleton CH; Stewart PM
    Nat Genet; 2003 Aug; 34(4):434-9. PubMed ID: 12858176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hexose-6-phosphate dehydrogenase confers oxo-reductase activity upon 11 beta-hydroxysteroid dehydrogenase type 1.
    Bujalska IJ; Draper N; Michailidou Z; Tomlinson JW; White PC; Chapman KE; Walker EA; Stewart PM
    J Mol Endocrinol; 2005 Jun; 34(3):675-84. PubMed ID: 15956339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. H6PDH interacts directly with 11beta-HSD1: implications for determining the directionality of glucocorticoid catalysis.
    Zhang YL; Zhong X; Gjoka Z; Li Y; Stochaj W; Stahl M; Kriz R; Tobin JF; Erbe D; Suri V
    Arch Biochem Biophys; 2009 Mar; 483(1):45-54. PubMed ID: 19121282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variants implicated in cortisone reductase deficiency do not contribute to susceptibility to common forms of polycystic ovary syndrome.
    Draper N; Powell BL; Franks S; Conway GS; Stewart PM; McCarthy MI
    Clin Endocrinol (Oxf); 2006 Jul; 65(1):64-70. PubMed ID: 16817821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study of the hexose-6-phosphate dehydrogenase gene R453Q and 11beta-hydroxysteroid dehydrogenase type 1 gene 83557insA polymorphisms in the polycystic ovary syndrome.
    San Millán JL; Botella-Carretero JI; Alvarez-Blasco F; Luque-Ramírez M; Sancho J; Moghetti P; Escobar-Morreale HF
    J Clin Endocrinol Metab; 2005 Jul; 90(7):4157-62. PubMed ID: 15827106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steroid biomarkers and genetic studies reveal inactivating mutations in hexose-6-phosphate dehydrogenase in patients with cortisone reductase deficiency.
    Lavery GG; Walker EA; Tiganescu A; Ride JP; Shackleton CH; Tomlinson JW; Connell JM; Ray DW; Biason-Lauber A; Malunowicz EM; Arlt W; Stewart PM
    J Clin Endocrinol Metab; 2008 Oct; 93(10):3827-32. PubMed ID: 18628520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Why is 11beta-hydroxysteroid dehydrogenase type 1 facing the endoplasmic reticulum lumen? Physiological relevance of the membrane topology of 11beta-HSD1.
    Odermatt A; Atanasov AG; Balazs Z; Schweizer RA; Nashev LG; Schuster D; Langer T
    Mol Cell Endocrinol; 2006 Mar; 248(1-2):15-23. PubMed ID: 16412558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hexose-6-phosphate dehydrogenase determines the reaction direction of 11beta-hydroxysteroid dehydrogenase type 1 as an oxoreductase.
    Atanasov AG; Nashev LG; Schweizer RA; Frick C; Odermatt A
    FEBS Lett; 2004 Jul; 571(1-3):129-33. PubMed ID: 15280030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 11beta-Hydroxysteroid dehydrogenase 1 reductase activity is dependent on a high ratio of NADPH/NADP(+) and is stimulated by extracellular glucose.
    Dzyakanchuk AA; Balázs Z; Nashev LG; Amrein KE; Odermatt A
    Mol Cell Endocrinol; 2009 Mar; 301(1-2):137-41. PubMed ID: 18778749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotypes at 11beta-hydroxysteroid dehydrogenase type 11B1 and hexose-6-phosphate dehydrogenase loci are not risk factors for apparent cortisone reductase deficiency in a large population-based sample.
    White PC
    J Clin Endocrinol Metab; 2005 Oct; 90(10):5880-3. PubMed ID: 16091483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response.
    Tomlinson JW; Walker EA; Bujalska IJ; Draper N; Lavery GG; Cooper MS; Hewison M; Stewart PM
    Endocr Rev; 2004 Oct; 25(5):831-66. PubMed ID: 15466942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Manifold effects of palmitoylcarnitine on endoplasmic reticulum metabolism: 11β-hydroxysteroid dehydrogenase 1, flux through hexose-6-phosphate dehydrogenase and NADPH concentration.
    Wang X; Mick GJ; Maser E; McCormick K
    Biochem J; 2011 Jul; 437(1):109-15. PubMed ID: 21492096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hexose-6-phosphate dehydrogenase modulates the effect of inhibitors and alternative substrates of 11beta-hydroxysteroid dehydrogenase 1.
    Balázs Z; Nashev LG; Chandsawangbhuwana C; Baker ME; Odermatt A
    Mol Cell Endocrinol; 2009 Mar; 301(1-2):117-22. PubMed ID: 19010388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constant expression of hexose-6-phosphate dehydrogenase during differentiation of human adipose-derived mesenchymal stem cells.
    Senesi S; Marcolongo P; Manini I; Fulceri R; Sorrentino V; Csala M; Bánhegyi G; Benedetti A
    J Mol Endocrinol; 2008 Sep; 41(3):125-33. PubMed ID: 18586838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human hypertension caused by mutations in the 11 beta-hydroxysteroid dehydrogenase gene: a molecular analysis of apparent mineralocorticoid excess.
    Whorwood CB; Stewart PM
    J Hypertens Suppl; 1996 Dec; 14(5):S19-24. PubMed ID: 9120678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physiological roles of 11 beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase.
    White PC; Rogoff D; McMillan DR
    Curr Opin Pediatr; 2008 Aug; 20(4):453-7. PubMed ID: 18622204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative enzymology of 11beta-hydroxysteroid dehydrogenase type 1 from six species.
    Arampatzis S; Kadereit B; Schuster D; Balazs Z; Schweizer RA; Frey FJ; Langer T; Odermatt A
    J Mol Endocrinol; 2005 Aug; 35(1):89-101. PubMed ID: 16087724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic reduction of the secondary bile acid 7-oxolithocholic acid is mediated by 11β-hydroxysteroid dehydrogenase 1.
    Odermatt A; Da Cunha T; Penno CA; Chandsawangbhuwana C; Reichert C; Wolf A; Dong M; Baker ME
    Biochem J; 2011 Jun; 436(3):621-9. PubMed ID: 21453287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic Coupling Determines the Activity: Comparison of 11β-Hydroxysteroid Dehydrogenase 1 and Its Coupling between Liver Parenchymal Cells and Testicular Leydig Cells.
    Li X; Hu G; Li X; Wang YY; Hu YY; Zhou H; Latif SA; Morris DJ; Chu Y; Zheng Z; Ge RS
    PLoS One; 2015; 10(11):e0141767. PubMed ID: 26528718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of 11beta-hydroxysteroid dehydrogenase 1 and 2 in subcutaneous adipose tissue of lean and obese women with and without polycystic ovary syndrome.
    Svendsen PF; Madsbad S; Nilas L; Paulsen SK; Pedersen SB
    Int J Obes (Lond); 2009 Nov; 33(11):1249-56. PubMed ID: 19704410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.